Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissues.

Hermann Brustmann1, Dominik Riss, Susanna Naudé

  • 1Department of Pathology, Landeskrankenhaus, Moedling/Vienna, Austria. ddrbrustmann@hotmail.com

Pathology, Research and Practice
|June 19, 2003
PubMed
Summary

Galectin-3 expression significantly increases in endometrial tissues from normal to hyperplastic, atypical hyperplastic, and cancerous states. This biomarker shows distinct expression levels correlating with endometrial cancer progression and grade.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Natural History Study and Long-Term Cochlear Implant Outcomes in Usher Syndrome Subtypes.

Ear and hearing·2026
Same author

Multicenter study results of the med-el partial ossicular replacement prostheses.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2025
Same author

Clinical outcomes of 188 patients implanted with Med-El stapes prostheses.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2025
Same author

Safety and Effectiveness of the Titanium mAXIS Stapes Prosthesis: Multicentric Short-Term Outcome.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025
Same author

Long-Term Results of Cochlear Implantation in Single-Sided Deaf Patients: Influence of Duration of Deafness and Age at Onset of Deafness.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2025
Same author

The association between acute otitis externa-related emergency department visits and extreme weather events in a temperate continental climate.

International journal of hygiene and environmental health·2024

Area of Science:

  • Gynecologic Pathology
  • Molecular Oncology
  • Biomarker Discovery

Background:

  • Galectin-3 is implicated in various cellular processes, including proliferation, apoptosis, and immune response.
  • Altered galectin-3 expression is observed in several human cancers, suggesting a role in tumorigenesis.
  • Understanding galectin-3's role in endometrial pathology is crucial for potential diagnostic and prognostic applications.

Purpose of the Study:

  • To evaluate galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissues.
  • To correlate galectin-3 expression levels with histologic type, grade, and stage of endometrial lesions.
  • To investigate the potential of galectin-3 as a biomarker in endometrial cancer progression.

Main Methods:

  • Immunohistochemistry was employed to assess galectin-3 expression in 101 endometrial curettage specimens.

Related Experiment Videos

  • Specimens included normal, hyperplastic (simple, complex without atypia, atypical), and neoplastic (endometrioid, serous, clear cell) endometrial tissues.
  • Immunostaining was quantified by percentage of positive cells and staining intensity, with statistical analysis (ANOVA, Newman-Keuls) applied.
  • Main Results:

    • Galectin-3 immunostaining scores significantly increased from normal/hyperplastic to atypical hyperplastic and carcinomatous tissues (p < 0.0001).
    • Three distinct expression levels were identified: (a) normal, simple hyperplasia, complex hyperplasia without atypia; (b) atypical hyperplasia, endometrioid adenocarcinoma; (c) serous papillary carcinoma, clear cell carcinoma.
    • Galectin-3 expression correlated positively with tumor grade (p = 0.0026), but not FIGO stage (p = 0.1687). Nuclear expression was enhanced in carcinomas, while stromal expression decreased.

    Conclusions:

    • Galectin-3 expression progressively increases from normal to malignant endometrial states, highlighting its role in endometrial tumorigenesis.
    • The distinct expression patterns suggest galectin-3 may differentiate between hyperplastic and neoplastic lesions and correlate with aggressiveness.
    • Findings support a continuum between atypical hyperplasia and endometrioid adenocarcinoma, with galectin-3 potentially serving as a valuable biomarker.